DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

MBG453 in Lower Risk MDS

Phase 2

Recruiting

Conditions: Myelodysplastic Syndromes

Interventions: Drug: MBG453

First Posted Date: 2021-04-01

Last Posted Date: 2024-03-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT04823624

Locations: 🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Augmented Infant Resuscitator to Enhance Newborn Ventilation

Not Applicable

Completed

Conditions: Perinatal Asphyxia
Asphyxia Neonatorum
Birth Asphyxia

Interventions: Device: AIR device without feedback
Device: Augmented Infant Resuscitator (AIR)

First Posted Date: 2021-03-29

Last Posted Date: 2021-03-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 270

Registration Number: NCT04820504

Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (Long-COVID)

Phase 4

Completed

Conditions: Covid19
Sequelae of; Infection
Cognitive Symptom

Interventions: Drug: Niagen

First Posted Date: 2021-03-22

Last Posted Date: 2024-03-20

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 70

Registration Number: NCT04809974

Locations: 🇺🇸
Clinical Translational Research Unit, Boston, Massachusetts, United States

Buspirone Treatment of Anxiety in Williams Syndrome

Phase 4

Completed

Conditions: Anxiety
Williams Syndrome

Interventions: Drug: Buspirone

First Posted Date: 2021-03-19

Last Posted Date: 2024-12-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT04807517

Locations: 🇺🇸
Lurie Center for Autism, Lexington, Massachusetts, United States

The Role of Fiber in the Prevention and Treatment of Fecal Incontinence

Not Applicable

Completed

Conditions: Fecal Incontinence
Irritable Bowel Syndrome With Diarrhea

Interventions: Dietary Supplement: Psyllium

First Posted Date: 2021-03-19

Last Posted Date: 2025-05-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 35

Registration Number: NCT04806386

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Venetoclax + Azacitidine vs. Induction Chemotherapy in AML

Phase 2

Recruiting

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Cytarabine
Drug: Venetoclax
Drug: Idarubicin
Drug: Azacitidine
Drug: Daunorubicin
Drug: Liposomal daunorubicin and cytarabine

First Posted Date: 2021-03-17

Last Posted Date: 2025-05-11

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 172

Registration Number: NCT04801797

Locations: 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸
University of California - Davis, Sacramento, California, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

and more 6 locations

Implementation of COVID-19 Testing Strategies in Community Health Centers

Not Applicable

Completed

Conditions: Covid19

Interventions: Other: Usual care control
Other: RADx CHCs testing intervention strategy

First Posted Date: 2021-03-17

Last Posted Date: 2023-11-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 6

Registration Number: NCT04802187

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Massachusetts League of Community Health Centers, Boston, Massachusetts, United States

MBCT Via Group Videoconferencing for Acute Coronary Syndrome Patients With Depressive Symptoms: A Pilot RCT

Not Applicable

Completed

Conditions: Cardiovascular Diseases
Acute Coronary Syndrome
Depression

Interventions: Behavioral: Adapted MBCT
Behavioral: Cardiac Health Enhancement

First Posted Date: 2021-03-16

Last Posted Date: 2025-01-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 24

Registration Number: NCT04799899

Locations: 🇺🇸
Mongan Institute: Health Policy Research Center, Boston, Massachusetts, United States

Improving Care for Peritoneal Dialysis Patients With the CKD-PD App

Not Applicable

Completed

Conditions: Peritoneal Dialysis Complication
Kidney Failure, Chronic

Interventions: Other: CKD-PD app with home monitoring equipment

First Posted Date: 2021-03-15

Last Posted Date: 2025-02-11

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 208

Registration Number: NCT04797195

Locations: 🇹🇭
Srinagarind Hospital, Khon Kaen, Thailand
🇹🇭
Khon Kaen Hospital, Khon Kaen, Thailand
🇹🇭
Chaiyaphum Hospital, Chaiyaphum, Thailand

Developing a Test for the Detection of Ovarian Cancer

Recruiting

Conditions: Fallopian Tube Neoplasms
Stage IIIA Ovarian Cancer AJCC v8
Stage IIIA1 Ovarian Cancer AJCC v8
Stage IV Ovarian Cancer AJCC v8
Ovarian Neoplasms
Ovarian Epithelial Carcinoma
High Grade Ovarian Serous Adenocarcinoma
Stage III Ovarian Cancer AJCC v8
Stage IIIC Ovarian Cancer AJCC v8
Stage IVB Ovarian Cancer AJCC v8

Interventions: Diagnostic Test: Uterine lavage, or a wash of the womb
Diagnostic Test: Blood sample
Diagnostic Test: Pap smear

First Posted Date: 2021-03-12

Last Posted Date: 2022-05-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 250

Registration Number: NCT04794322

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸
Kaiser Permanente - San Francisco, San Francisco, California, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy